Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-06-07
1977-05-31
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2523011R, 424 15, A61K 2900, A61K 4300
Patent
active
040270050
ABSTRACT:
Radionuclide diagnostic agents, comprising technetium-99m, a reducing agent, preferably a stannous reducing agent, and certain polyhydroxycarboxylic acids and derivatives thereof, i.e. glucoheptonic acid, lactobionic acid, galacturonic acid and glucuronic acid and salts thereof, are highly useful, both in the study and diagnosis of kidney morphology and function, and in the diagnosis of ischemic, infarcted or diseased tissue.
REFERENCES:
patent: 3725295 (1973-04-01), Eckelman et al.
patent: 3749556 (1973-07-01), Barak et al.
Adler Norman
Camin Leopoldo Lazaro
Gold Paul
Bronstein Sewall P.
Conlin David G.
New England Nuclear Corporation
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Diagnostic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-658552